How to buy R1 RCM stock - 15 April

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy R1 RCM stock

Own R1 RCM stock in just a few minutes.

R1 RCM Inc is a health information services business based in the US. R1 RCM shares (RCM) are listed on the NASDAQ and all prices are listed in US Dollars. R1 RCM employs 19,000 staff and has a trailing 12-month revenue of around USD$1.3 billion.

How to buy shares in R1 RCM

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for R1 RCM. Find the stock by name or ticker symbol: RCM. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until R1 RCM reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of R1 RCM, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of R1 RCM. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

R1 RCM share price

Use our graph to track the performance of RCM stocks over time.

R1 RCM shares at a glance

Information last updated 2021-04-09.
52-week rangeUSD$8.46 - USD$31.28
50-day moving average USD$26.1863
200-day moving average USD$22.7128
Wall St. target priceUSD$35.17
PE ratio 76.8502
Dividend yield N/A (0%)
Earnings per share (TTM) USD$0.327

Buy R1 RCM shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
N/A
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs, Gold/Commodities
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy R1 RCM stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is R1 RCM under- or over-valued?

Valuing R1 RCM stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of R1 RCM's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

R1 RCM's P/E ratio

R1 RCM's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 77x. In other words, R1 RCM shares trade at around 77x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

R1 RCM's PEG ratio

R1 RCM's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.3902. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into R1 RCM's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

R1 RCM's EBITDA

R1 RCM's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$212.6 million.

The EBITDA is a measure of a R1 RCM's overall financial performance and is widely used to measure a its profitability.

R1 RCM financials

Revenue TTM USD$1.3 billion
Operating margin TTM 11.32%
Gross profit TTM USD$249.7 million
Return on assets TTM 8.49%
Return on equity TTM 39.93%
Profit margin 9.22%
Book value $0.726
Market capitalisation USD$6.6 billion

TTM: trailing 12 months

Shorting R1 RCM shares

There are currently 3.0 million R1 RCM shares held short by investors – that's known as R1 RCM's "short interest". This figure is 9.2% down from 3.3 million last month.

There are a few different ways that this level of interest in shorting R1 RCM shares can be evaluated.

R1 RCM's "short interest ratio" (SIR)

R1 RCM's "short interest ratio" (SIR) is the quantity of R1 RCM shares currently shorted divided by the average quantity of R1 RCM shares traded daily (recently around 1.3 million). R1 RCM's SIR currently stands at 2.37. In other words for every 100,000 R1 RCM shares traded daily on the market, roughly 2370 shares are currently held short.

However R1 RCM's short interest can also be evaluated against the total number of R1 RCM shares, or, against the total number of tradable R1 RCM shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case R1 RCM's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 R1 RCM shares in existence, roughly 10 shares are currently held short) or 0.0117% of the tradable shares (for every 100,000 tradable R1 RCM shares, roughly 12 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against R1 RCM.

Find out more about how you can short R1 RCM stock.

R1 RCM share dividends

We're not expecting R1 RCM to pay a dividend over the next 12 months.

R1 RCM share price volatility

Over the last 12 months, R1 RCM's shares have ranged in value from as little as $8.46 up to $31.28. A popular way to gauge a stock's volatility is its "beta".

RCM.US volatility(beta: 0.8)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while R1 RCM's is 0.7987. This would suggest that R1 RCM's shares are less volatile than average (for this exchange).

R1 RCM overview

R1 RCM Inc. provides revenue cycle management (RCM) for healthcare providers in the United States. The company offers end-to-end RCM services to manage their revenue cycle operations that encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, bill preparation, and collections from patients and payers. It also provides modular services comprising physician advisory services, which assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; practice management services that offers administrative and operational support for patient care and outsource non-core functions; revenue integrity solutions, including charge capture, charge description master maintenance, and pricing services; coding management services, such as business intelligence and analysis, human capital management, accountability framework, and quality management programs; patient experience; and business office services. In addition, the company offers software-as-a-service based scheduling and patient access solutions. It serves healthcare providers, including health systems, hospitals, and physician groups. The company was formerly known as Accretive Health, Inc. and changed its name to R1 RCM Inc. in January 2017. R1 RCM Inc. was incorporated in 2003 and is headquartered in Chicago, Illinois.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site